open access

Vol 27, No 2 (2020)
Letters to the Editor — Clinical cardiology
Published online: 2020-05-18
Get Citation

Moderate to severe ischemic mitral regurgitation: More data to guide the choice. Why not consider the use of subvalvular repair?

Antonio Nenna, Massimo Chello, Francesco Nappi
DOI: 10.5603/CJ.2020.0051
·
Pubmed: 32463103
·
Cardiol J 2020;27(2):220-222.

open access

Vol 27, No 2 (2020)
Letters to the Editor — Clinical cardiology
Published online: 2020-05-18

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

mitral valve, ischemic mitral regurgitation, subvalvular, annular

About this article
Title

Moderate to severe ischemic mitral regurgitation: More data to guide the choice. Why not consider the use of subvalvular repair?

Journal

Cardiology Journal

Issue

Vol 27, No 2 (2020)

Pages

220-222

Published online

2020-05-18

DOI

10.5603/CJ.2020.0051

Pubmed

32463103

Bibliographic record

Cardiol J 2020;27(2):220-222.

Keywords

mitral valve
ischemic mitral regurgitation
subvalvular
annular

Authors

Antonio Nenna
Massimo Chello
Francesco Nappi

References (10)
  1. Li B, Wu H, Sun H, et al. Long-term outcomes of mitral valve annuloplasty versus subvalvular sparing replacement for severe ischemic mitral regurgitation. Cardiol J. 2019; 26(3): 265–274.
  2. Nappi F, Lusini M, Avtaar Singh SS, et al. Risk of ischemic mitral regurgitation recurrence after combined valvular and subvalvular repair. Ann Thorac Surg. 2019; 108(2): 536–543.
  3. Nappi F, Spadaccio C, Nenna A, et al. Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the Papillary Muscle Approximation trial. J Thorac Cardiovasc Surg. 2017; 153(2): 286–295.e2.
  4. Nappi F, Spadaccio C, Nenna A, et al. Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation. J Am Coll Cardiol. 2016; 67(20): 2334–2346.
  5. Harmel E, Pausch J, Gross T, et al. Standardized subannular repair improves outcomes in type iiib functional mitral regurgitation. Ann Thorac Surg. 2019; 108(6): 1783–1792.
  6. Li B, Wu H, Sun H, et al. Predicting functional mitral stenosis after restrictive annuloplasty for ischemic mitral regurgitation. Cardiol J. 2019; 26(4): 350–359.
  7. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70: 252–289.
  8. Michler RE, Smith PK, Parides MK, et al. Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med. 2016; 374(20): 1932–1941.
  9. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001; 104(12 Suppl 1): I68–I75.
  10. Goldstein D, Moskowitz AJ, Gelijns AC, et al. CTSN. Two-Year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016; 374(4): 344–353.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl